UC Irvine receives funding for clinical trial of neural stem cell therapy for Huntington’s disease
Why Stem‑Cell Therapy Could Redefine Huntington’s Disease Care Scientists are closing in on a breakthrough that may shift Huntington’s disease (HD) from a relentless neurodegenerative disorder to a treatable condition. The California Institute for Regenerative Medicine (CIRM) has funneled nearly $12 million into a first‑in‑human trial of an embryonic‑stem‑cell‑derived neural stem cell product, dubbed hNSC‑01. This … Read more